Susan O'Brien
Associate Director for Clinical Science, Chao Family Comprehensive Cancer Center · University of California
Credentials: · · · · ·
History
- Present
Sue & Ralph Stern Center for Clinical Trials & Research · University of California
- Present
- 1983–1985
Medical Oncology
- 1980–1983
Internal Medicine
Research
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2013 · Last of 21 authors · 1,914 citations
Blood · 1996 · 1,521 citations
Blood · 2018 · 1,415 citations

674 papers

377 papers · 15 as a fellow
- MK
359 papers

224 papers

222 papers · 2 as a fellow
- FG
204 papers
- SF
201 papers · 53 as a fellow

179 papers · 10 as a fellow
Clinical trials
- 2013
IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
- 2007–2010
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Principal investigator · Completed · Phase 2
Spectrum Pharmaceuticals, Inc
- 2007–2014
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
- 2006–2012
Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
